leisure time -WSS

leisure time

author：leisure time 2025-09-02 22:26:40 - browse：94

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： States increasingly look to regulate hospital facility fees

entertainment

WSS

Man who had jail sentence commuted by Trump arrested again

DOJ, FTC to increase scrutiny of all types of health care mergers

DOJ, FTC to increase scrutiny of all types of health care mergers

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Man who had jail sentence commuted by Trump arrested again

DOJ, FTC to increase scrutiny of all types of health care mergers

focus

leisure time

Wikipedia

Virginia high school admissions case could be legal follow

The kidney, in all its complexity, is captured in a new atlas

Hepatitis C has a cure — but many Americans still lack access to it

TikTok cracks down on users posting about weight loss drugs

Heart attack and stroke risk calculators need revising

How dance can help health care workers heal from trauma

Duchenne breakthrough therapy leaves behind pioneering families

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Guidelines to prevent youth baseball injuries need more muscle

India sets sights on home

hotspot

Researchers separate signal from noise in heart wearable data

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Trump got a 'target letter.' What is one and what does it mean?

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

How dance can help health care workers heal from trauma

How dance can help health care workers heal from trauma

hotspot

knowledge

entertainment

leisure time